Completed
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
NCT00010387
- Conditions
- Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +28 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States